COVID-19 infection has shown rapid growth worldwide, and different therapies have been proposed for treatment, in particular, the combination of immune response modulating drugs such as chloroquine and hydroxychloroquine (antimalarials) alone or in combination with azithromycin. Although the clinical evidence supporting their use is scarce, the off label use of these drugs has spread very quickly in face of the progression of the epidemic and the high mortality rate in susceptible populations. However, these medications can pathologically prolong the QT interval and lead to malignant ventricular arrhythmias such that organized guidance on QT evaluation and management strategies are important to reduce morbidity associated with the potential large-scale use.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229438PMC
http://dx.doi.org/10.1007/s10840-020-00765-3DOI Listing

Publication Analysis

Top Keywords

covid-19 infection
8
recommendations measurement
4
measurement interval
4
interval drugs
4
drugs covid-19
4
infection treatment
4
treatment updatable
4
updatable availability
4
availability evidence
4
evidence covid-19
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!